Mitsubishi Tanabe Pharma Corporation http://www.mt-pharma.co.jp/e/ en [IR Calendar] Announcement of FY2011 3rd Quater Financial Results http://www.mt-pharma.co.jp/e/ir/calendar.php#20120131000026 Tue, 31 Jan 2012 00:00:00 +0900 [Topics] Conference Call for FY2011 3rd Quarter Business Results [Material][Audio] http://www.mt-pharma.co.jp/e/release/topics.php#201201310000240 Tue, 31 Jan 2012 00:00:00 +0900 [Investor Relations] Financial Results for FY2011 3Q【January 31, 2012】 http://www.mt-pharma.co.jp/e/ir/index.php#20120131000018 Tue, 31 Jan 2012 00:00:00 +0900 [News Release] Announcement of FY2011 3rd Quarter Financial Results http://www.mt-pharma.co.jp/e/release/index.php#201201310000162 Tue, 31 Jan 2012 00:00:00 +0900 [Topics] R&D "Clinical Trial Information" http://www.mt-pharma.co.jp/e/release/topics.php#201201230000239 Mon, 23 Jan 2012 00:00:00 +0900 [News Release] Conclusion of Licensing Agreement for Hib Vaccine http://www.mt-pharma.co.jp/e/release/index.php#201201160000161 Mon, 16 Jan 2012 00:00:00 +0900 [Topics] R&D "Clinical Trial Information" http://www.mt-pharma.co.jp/e/release/topics.php#201112160000238 Fri, 16 Dec 2011 00:00:00 +0900 [News Release] Dainippon Sumitomo Pharma and Yoshitomiyakuhinterminate co-promotion of antipsychotics, LONASEN and LULLAN http://www.mt-pharma.co.jp/e/release/index.php#201112010000160 Thu, 01 Dec 2011 00:00:00 +0900 [News Release] Launch of "IMUSERA Capsules 0.5mg"Japan's First Oral Dosing Multiple Sclerosis Treatment with Novel Mode of Action http://www.mt-pharma.co.jp/e/release/index.php#201111250000159 Fri, 25 Nov 2011 00:00:00 +0900 [News Release] Launch of Antiviral Agent "TELAVIC Tablets 250 mg"Novel Mode of Action for Chronic Hepatitis C Treatment http://www.mt-pharma.co.jp/e/release/index.php#201111250000158 Fri, 25 Nov 2011 00:00:00 +0900